Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

SEHK:2315 Stock Report

Market Cap: HK$2.3b

Biocytogen Pharmaceuticals (Beijing) Management

Management criteria checks 4/4

We currently do not have sufficient information about the CEO.

Key information

Yuelei Shen

Chief executive officer

CN¥2.1m

Total compensation

CEO salary percentage86.6%
CEO tenure15yrs
CEO ownership6.6%
Management average tenure5.3yrs
Board average tenure4.6yrs

Recent management updates

Recent updates

Is Biocytogen Pharmaceuticals (Beijing) (HKG:2315) A Risky Investment?

May 08
Is Biocytogen Pharmaceuticals (Beijing) (HKG:2315) A Risky Investment?

Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s (HKG:2315) Price Is Right But Growth Is Lacking

Apr 03
Biocytogen Pharmaceuticals (Beijing) Co., Ltd.'s (HKG:2315) Price Is Right But Growth Is Lacking

CEO Compensation Analysis

How has Yuelei Shen's remuneration changed compared to Biocytogen Pharmaceuticals (Beijing)'s earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥244m

Mar 31 2024n/an/a

-CN¥313m

Dec 31 2023CN¥2mCN¥2m

-CN¥383m

Sep 30 2023n/an/a

-CN¥451m

Jun 30 2023n/an/a

-CN¥519m

Mar 31 2023n/an/a

-CN¥561m

Dec 31 2022CN¥3mCN¥2m

-CN¥602m

Sep 30 2022n/an/a

-CN¥585m

Jun 30 2022n/an/a

-CN¥569m

Mar 31 2022n/an/a

-CN¥557m

Dec 31 2021CN¥6mCN¥2m

-CN¥546m

Dec 31 2020CN¥120mCN¥2m

-CN¥217m

Compensation vs Market: Yuelei's total compensation ($USD285.47K) is about average for companies of similar size in the Hong Kong market ($USD352.01K).

Compensation vs Earnings: Yuelei's compensation has been consistent with company performance over the past year.

CEO

Yuelei Shen (54 yo)

15yrs

Tenure

CN¥2,058,000

Compensation

Dr. Yuelei Shen, Ph D., is the Founder and Chief Executive Officer of Eucure (Beijing) Biopharma Co., Ltd., and its General Manager and Executive Director since August 2021. Dr. Shen is Chairman, President...

Leadership Team

NamePositionTenureCompensationOwnership
Yuelei Shen
Chairman of the Board15yrsCN¥2.06m6.61%
HK$ 152.0m
Jian Ni
Executive Director15yrsno data7.26%
HK$ 167.1m
Haichao Zhang
Senior Operation Director of Animal Center & Executive Director5.3yrsCN¥1.01mno data
Bin Liu
CFO & Deputy GM4.5yrsno datano data
Yi Yang
Chief Scientific Officer & Deputy GM4.8yrsno datano data
Chaoshe Guo
VP of Marketing & Deputy GM9.4yrsno datano data
Chunli Sun
Director of Human Resources & Supervisor4.3yrsno datano data
Yan Li
Chairman of the Supervisory Committee & Director of the President’s Office9.3yrsno datano data
Qingcong Lin
Deputy GM & CEO of Biocytogen Boston Corp.6.8yrsno datano data
Yongliang Wang
Deputy GM3.3yrsno datano data
Wai Au
Joint Company Secretary2.3yrsno datano data

5.3yrs

Average Tenure

48yo

Average Age

Experienced Management: 2315's management team is seasoned and experienced (5.3 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yuelei Shen
Chairman of the Board15yrsCN¥2.06m6.61%
HK$ 152.0m
Jian Ni
Executive Director15yrsno data7.26%
HK$ 167.1m
Haichao Zhang
Senior Operation Director of Animal Center & Executive Director5.3yrsCN¥1.01mno data
Chunli Sun
Director of Human Resources & Supervisor3.9yrsno datano data
Yan Li
Chairman of the Supervisory Committee & Director of the President’s Office5.3yrsno datano data
Fengmao Hua
Independent Non-Executive Director3.3yrsCN¥120.00kno data
Leidi Zhang
Non-Executive Director2yrsno datano data
Kexiang Zhou
Non-Executive Director6.7yrsno datano data
Yiliang Wei
Non-Executive Director9.2yrsno datano data
Changyuan Yu
Independent Non-Executive Director3.9yrsCN¥120.00kno data
Xiaoyan Liang
Independent Non-Executive Director3.9yrsCN¥120.00kno data
Jiawei Yao
Supervisor2yrsno datano data

4.6yrs

Average Tenure

52yo

Average Age

Experienced Board: 2315's board of directors are considered experienced (4.6 years average tenure).